Pendulum Therapeutics
The Next Generation of Probiotics.
San Francisco Bay Area, United States · Founded 2014 · $120.9M raised
- Headquarters
- San Francisco Bay Area, California
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2C
- Website
- wholebiome.com
- Total Funding
- $120.9M
- Last Round
- $10.0M Corporate RoundJun 2023
- Rounds
- 5
About
Pendulum Therapeutics is a microbiome science company that develops next-generation probiotics targeting the gut microbiome to improve metabolic health. Its clinically validated products include strains like Akkermansia muciniphila and formulations shown to reduce blood sugar in Type 2 diabetes. Pendulum sells direct-to-consumer and through healthcare practitioners, recently expanding to GLP-1 and sports performance formulations.
Summary
Pendulum Therapeutics is a Biotech company based in San Francisco Bay Area, United States, founded in 2014. It has raised $120.9M in total across 5 rounds, most recently a $10.0M Corporate Round round in Jun 2023. Investors include True Ventures, Fonterra and Meritech Capital Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2023
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...